Molecular Targets of the Phytocannabinoids: A Complex Picture
- 25 January 2017
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 103, 103-131
- https://doi.org/10.1007/978-3-319-45541-9_4
Abstract
For centuries, hashish and marihuana, both derived from the Indian hemp Cannabis sativa L., have been used for their medicinal, as well as, their psychotropic effects. These effects are associated with the phytocannabinoids which are oxygen containing C21 aromatic hydrocarbons found in Cannabis sativa L. To date, over 120 phytocannabinoids have been isolated from Cannabis. For many years, it was assumed that the beneficial effects of the phytocannabinoids were mediated by the cannabinoid receptors, CB1 and CB2. However, today we know that the picture is much more complex, with the same phytocannabinoid acting at multiple targets. This contribution focuses on the molecular pharmacology of the phytocannabinoids, including Δ9-THC and CBD, from the prospective of the targets at which these important compounds act.Keywords
This publication has 128 references indexed in Scilit:
- Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinomaCell Death & Disease, 2013
- Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesiaNature Chemical Biology, 2011
- Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesiaTrends in Pharmacological Sciences, 2009
- The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarinBritish Journal of Pharmacology, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Cannabinoid activation of PPARα; a novel neuroprotective mechanismBritish Journal of Pharmacology, 2007
- Cannabinoids go nuclear: evidence for activation of peroxisome proliferator‐activated receptorsBritish Journal of Pharmacology, 2007
- Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differencesBritish Journal of Pharmacology, 2007
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitroBritish Journal of Pharmacology, 2007
- The psychoactive plant cannabinoid, Δ9‐tetrahydrocannabinol, is antagonized by Δ8‐ and Δ9‐tetrahydrocannabivarin in mice in vivoBritish Journal of Pharmacology, 2007